Samantha Kay Kizzire

Samantha Kay Kizzire ( SAMANTHA KAY KIZZIRE ) is Definition Nurse Practitioner Physician in Osmond, NE. The NPI Number for Samantha Kay Kizzire is 1821694639.

The current location address for Samantha Kay Kizzire is 402 N MAPLE ST Osmond, NE 68765 and the contact number is 4024501377 and fax number is . The mailing address for Samantha Kay Kizzire is 1720 N ST Gering, NE 69341- 4027483393 (mailing address contact number - 4024501377).

Definition to come...

What is the NPI Number for Samantha Kay Kizzire ?

Answer: The NPI Number for Samantha Kay Kizzire is 1821694639

Where is Samantha Kay Kizzire located?

Answer: Samantha Kay Kizzire is located at 402 N MAPLE ST Osmond, NE 68765.

What is the specialty for Samantha Kay Kizzire ?

Answer: The Specialty of Samantha Kay Kizzire is Definition Nurse Practitioner Physician.

Are there any online reviews for Samantha Kay Kizzire ?

Answer: Not yet!

Are there any other health care providers in Osmond, NE?

Answer: Yes, there are given below...

Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Samantha Kay Kizzire

Number of HCPCS	32
Number of Medicare Beneficiaries	40
Number of Services	96
Total Submitted Charge Amount	12492.5
Total Medicare Allowed Amount	4899.66
Total Medicare Payment Amount	3865.98
Total Medicare Standardized Payment Amount	4127.41
Drug Suppress Indicator	*
Number of HCPCS Associated With Drug Services
Number of Medicare Beneficiaries With Drug Services
Number of Drug Services
Total Drug Submitted Charge Amount
Total Drug Medicare Allowed Amount
Total Drug Medicare Payment Amount
Total Drug Medicare Standardized Payment Amount
Medical Suppress Indicator	#
Number of HCPCS Associated With Medical Services
Number of Medicare Beneficiaries With Medical
Number of Medical Services
Total Medical Submitted Charge Amount
Total Medical Medicare Allowed Amount
Total Medical Medicare Payment Amount
Total Medical Medicare Standardized Payment Amount
Average Age of Beneficiaries	79
Number of Beneficiaries Age Less 65
Number of Beneficiaries Age 65 to 74	13
Number of Beneficiaries Age 75 to 84	14
Number of Beneficiaries Age Greater 84
Number of Female Beneficiaries	24
Number of Male Beneficiaries	16
Number of Non-Hispanic White Beneficiaries
Number of Black or African American Beneficiaries
Number of Asian Pacific Islander Beneficiaries
Number of Hispanic Beneficiaries
Number of American Indian/Alaska Native Beneficiaries
Number of Beneficiaries With Race Not Elsewhere Classified
Number of Beneficiaries With Medicare & Medicaid Entitlement
Number of Beneficiaries With Medicare Only Entitlement
Percent (%) of Beneficiaries Identified With Atrial Fibrillation
Percent (%) of Beneficiaries Identified With Alzheimer's Disease or Dementia
Percent (%) of Beneficiaries Identified With Asthma
Percent (%) of Beneficiaries Identified With Cancer
Percent (%) of Beneficiaries Identified With Heart Failure
Percent (%) of Beneficiaries Identified With Chronic Kidney Disease
Percent (%) of Beneficiaries Identified With Chronic Obstructive Pulmonary Disease
Percent (%) of Beneficiaries Identified With Depression
Percent (%) of Beneficiaries Identified With Diabetes
Percent (%) of Beneficiaries Identified With Hyperlipidemia	0.5
Percent (%) of Beneficiaries Identified With Hypertension	0.68
Percent (%) of Beneficiaries Identified With Ischemic Heart Disease	0.35
Percent (%) of Beneficiaries Identified With Osteoporosis
Percent (%) of Beneficiaries Identified With Rheumatoid Arthritis / Osteoarthritis	0.35
Percent (%) of Beneficiaries Identified With Schizophrenia / Other Psychotic Disorders	0
Percent (%) of Beneficiaries Identified With Stroke
Average HCC Risk Score of Beneficiaries	1.1715

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Nurse Practitioner
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	191
Number of Standardized 30-Day Fills	225.7
Aggregate Cost Paid for All Claims	3516.83
Number of Day's Supply for All Claims	4329
Number of Medicare Beneficiaries	98
Number of Claims, Including Refills, for Beneficiaries Age 65+	176
Including Refills, for Beneficiaries Age 65+	198.7
Beneficiaries Age 65+	3091.73
Number of Day's Supply for All Claims for Beneficaries Age 65+	3659
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	*
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	185
Aggregate Cost Paid for Generic Drugs	2395.98
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst	#
Total Claims of Other Drugs, Including Refills
Aggregate Cost Paid for Other Drugs
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	39
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	679.85
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	152
Aggregate Cost Paid for Claims Filled by	2836.98
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	15
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	434.72
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	176
by Low-Income Subsidy	3082.11
Total Claims of Opioid Drugs, Including
Aggregate Cost Paid for Opioid Drugs
Opioid Claims
Opioid_Tot_Clms divided by the Tot_Clms
Total Claims of Long-Acting Opioid Drugs
Aggregate Cost Paid for Long-Acting Opioid
Number of Day's Supply of All Long-Acting
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	72
Aggregate Cost Paid for Antibiotic Drugs	590.88
Antibiotic Claims	57
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	75.632653061
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries	61
Number of Male Beneficiaries	37
Number of Non-Hispanic White	97
Number of Black or African American
Number of Asian Pacific Islander	0
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not	0
Only Entitlement
Average Hierarchical Condition Category	0.866081905